What is the recommended treatment for a patient with 70% stenosis of the right carotid artery and a normal left carotid artery?

Treatment for 70% Right Carotid Stenosis with Normal Left Carotid

For a patient with 70% right carotid stenosis and a normal left carotid artery, the treatment depends critically on whether the stenosis is symptomatic or asymptomatic—if symptomatic (recent stroke, TIA, or amaurosis fugax within 6 months), carotid endarterectomy (CEA) should be performed urgently within 14 days; if asymptomatic, CEA may be considered but only if life expectancy exceeds 3-5 years and perioperative risk is <3%, with optimal medical therapy being mandatory regardless of intervention choice.

Symptomatic vs. Asymptomatic: The Critical Distinction

The first step is determining symptom status:

Symptomatic stenosis includes:

• Ipsilateral stroke (non-disabling) within past 6 months
• Transient ischemic attack (TIA) with hemispheric symptoms
• Amaurosis fugax (transient monocular blindness)

If symptomatic with 70% stenosis:

• CEA is strongly recommended with anticipated perioperative stroke/death rate <6% 1
• Timing is critical: Perform within 14 days of the index event, ideally within 48 hours to 14 days once neurologically stable 2
• Carotid artery stenting (CAS) is an alternative if perioperative risk <6%, particularly for younger patients (<70 years) or those with unfavorable surgical anatomy 1

If asymptomatic with 70% stenosis:

• CEA may be considered but only if perioperative stroke/MI/death risk is <3% and life expectancy >3-5 years 1, 3, 4
• The benefit is modest—absolute risk reduction is small with modern medical therapy
• Patient selection requires careful assessment of comorbidities and individual stroke risk factors 1

Mandatory Medical Therapy (All Patients)

Regardless of whether revascularization is performed, optimal medical therapy (OMT) is essential 2:

Antiplatelet Therapy

• Aspirin 81-325 mg daily is the foundation 1
• For symptomatic patients not undergoing revascularization: Dual antiplatelet therapy (DAPT) with aspirin plus clopidogrel 75 mg for 21 days, then clopidogrel alone long-term 2
• Avoid DAPT beyond 21-90 days in stroke patients not undergoing intervention (increased bleeding risk without clear benefit) 1

Lipid Management

• High-intensity statin therapy targeting LDL-C <1.4 mmol/L (55 mg/dL) with >50% reduction from baseline 2, 5

Blood Pressure Control

• Aggressive antihypertensive therapy per current guidelines 3
• Target appropriate BP goals while avoiding hypotension

Additional Risk Factor Management

• Smoking cessation with pharmacologic support if needed
• Diabetes management (prefer SGLT2 inhibitors and GLP-1 receptor agonists for CV benefits) 5
• Mediterranean-style diet and regular physical activity 5

Revascularization Decision Algorithm

For Symptomatic 70% Stenosis:

1. Confirm stenosis severity with duplex ultrasound as first-line, consider CTA/MRA for confirmation 2
2. Assess surgical risk and patient age
3. CEA is preferred for most patients, especially those >70 years 3
4. Consider CAS if:
   • Age <70 years 3
   • Unfavorable neck anatomy for surgery (prior neck surgery, radiation, high lesion) 1
   • Medical comorbidities increasing surgical risk
5. Timing: Perform within 14 days, ideally 48 hours to 14 days after symptom onset 2

For Asymptomatic 70% Stenosis:

1. Evaluate life expectancy (must be >3-5 years for benefit) 3, 4
2. Assess high-risk features:
   • Rapidly progressive stenosis
   • Silent infarcts on imaging
   • Contralateral carotid occlusion
   • Poor collateral circulation
3. Verify institutional/surgeon quality: Perioperative stroke/death rate must be <3% 3, 4
4. Shared decision-making with patient regarding risks/benefits 1
5. If revascularization deferred, annual surveillance with duplex ultrasound 6, 1

Perioperative Management (If Revascularization Chosen)

For CEA:

• Aspirin 81-325 mg daily before and continued indefinitely after 1
• Blood pressure control perioperatively 6, 1
• Neurological examination within 24 hours pre- and post-procedure 6, 1

For CAS:

• DAPT with aspirin 81-325 mg plus clopidogrel 75 mg starting before procedure and continuing minimum 30 days 6, 1, 2
• After 30 days, transition to single antiplatelet (aspirin or clopidogrel) long-term 2
• Embolic protection device deployment recommended 6, 1
• Strict blood pressure control 6, 1

Follow-Up Surveillance

• Duplex ultrasound at 1 month, 6 months, then annually after revascularization 6, 1, 2
• Annual assessment of cardiovascular risk factors and medication compliance 2
• Neurological symptom monitoring at each visit 2

Critical Caveats

Do NOT revascularize if:

• Stenosis <50% (no benefit) 1
• Complete carotid occlusion 1
• Severe disability from prior stroke (Modified Rankin Scale ≥3) 1
• Life expectancy <3-5 years for asymptomatic stenosis 3, 4
• Institutional perioperative complication rates exceed guideline thresholds

Age considerations: CEA is generally preferred over CAS in patients >70 years due to higher periprocedural stroke risk with stenting in older patients 3. Conversely, CAS may be considered in younger patients (<70 years) with symptomatic stenosis 3.

The most recent high-quality evidence from the 2024 ESC guidelines 2 emphasizes that OMT is mandatory for all patients, and revascularization decisions must be individualized based on symptom status, stenosis severity, life expectancy, and institutional expertise.